Table 4 |
|||||
|
Comparison of pathologic features of ER-positive BRCA1-associated breast cancers and ER-positive sporadic breast cancers |
|||||
|
Covariates |
BRCA1 + |
Sporadic |
|||
|
|
|||||
|
n |
% |
N |
% |
Logistic likelihood ratio test P |
|
|
|
|||||
|
All |
47 |
100 |
138 |
100 |
|
|
|
|||||
|
Mean age in years (range) |
46 (29-72) |
46 (29-72) |
|||
|
|
|||||
|
Histologic type |
|||||
|
|
|||||
|
Invasive ductal only |
35 |
74 |
78 |
57 |
0.03 |
|
|
|||||
|
All others |
12 |
26 |
60 |
43 |
|
|
|
|||||
|
Mixed ductal/lobular |
10 |
21 |
25 |
18 |
|
|
|
|||||
|
Lobular |
1 |
2 |
12 |
9 |
|
|
|
|||||
|
Mixed ductal + special type |
0 |
0 |
8* |
6 |
|
|
|
|||||
|
Special type |
1+ |
2 |
15++ |
11 |
|
|
|
|||||
|
Histologic grade |
|||||
|
|
|||||
|
3 |
18 |
38 |
34 |
25 |
0.10 |
|
|
|||||
|
2 |
15 |
32 |
69 |
50 |
0.39 |
|
|
|||||
|
1 |
13 |
28 |
35 |
25 |
0.69 |
|
|
|||||
|
Unknown |
1 |
2 |
0 |
0 |
|
|
|
|||||
|
Mitoses/10 HPF |
|||||
|
|
|||||
|
>10 |
9 |
19 |
9 |
7 |
0.03 |
|
|
|||||
|
6-10 |
12 |
26 |
31 |
22 |
0.67 |
|
|
|||||
|
0-5 |
25 |
53 |
98 |
71 |
0.03 |
|
|
|||||
|
Unknown |
1 |
2 |
0 |
0 |
|
|
|
|||||
|
Margins |
|||||
|
|
|||||
|
Invasive |
43 |
91 |
134 |
97 |
0.12 |
|
|
|||||
|
Pushing |
3 |
6 |
2 |
1 |
0.09 |
|
|
|||||
|
Unknown |
1 |
2 |
2 |
1 |
|
|
|
|||||
|
Lymphocytic infiltrate |
|||||
|
|
|||||
|
Moderate/marked |
2 |
4 |
17 |
12 |
0.08 |
|
|
|||||
|
None/mild |
44 |
94 |
121 |
88 |
|
|
|
|||||
|
Unknown |
1 |
2 |
0 |
0 |
|
|
|
|||||
|
Geographic necrosis/fibrotic focus |
|||||
|
|
|||||
|
Yes |
7 |
15 |
9 |
7 |
0.09 |
|
|
|||||
|
No |
38 |
81 |
129 |
93 |
|
|
|
|||||
|
Unknown |
2 |
4 |
0 |
0 |
|
|
|
|||||
|
ER, estrogen receptor; HPF, high powered field. Percentages calculated by column * Mixed ductal plus: mucinous (n = 4), invasive micropapillary (n = 2), invasive papillary (n = 1), tubular (n = 1) + tubular (n = 1) ++ tubular (n = 6), mucinous (n = 5), invasive micropapillary (n = 2), invasive cribriform (n = 1), mixed invasive micropapillary/mucinous (n = 1) |
|||||
|
Tung et al. Breast Cancer Research 2010 12:R12 doi:10.1186/bcr2478 |
|||||